Abstract
Among the most significant findings in the pathogenesis of HIV infection was the discovery that almost total depletion of intestinal CD4+ T cells occurs rapidly after SIV or HIV infection, regardless of the route of exposure, and long before CD4+ T cell losses occur in blood or lymph nodes. Since these seminal discoveries, we have learned much about mucosal and systemic CD4+ T cells, and found several key differences between the circulating and intestinal CD4+ T cell subsets, both in phenotype, relative proportions, and functional capabilities. Further, specific subsets of CD4+ T cells are selectively targeted and eliminated first, especially cells critically important for initiating primary immune responses, and for maintenance of mucosal integrity (Th1, Th17, and Th22 cells). This simultaneously results in loss of innate immune responses, and loss of mucosal integrity, resulting in mucosal, and systemic immune activation that drives proliferation and activation of new target cells throughout the course of infection. The propensity for the SIV/HIV to infect and efficiently replicate in specific cells also permits viral persistence, as the mucosal and systemic activation that ensues continues to damage mucosal barriers, resulting in continued influx of target cells to maintain viral replication. Finally, infection and elimination of recently activated and proliferating CD4+ T cells, and infection and dysregulation of Tfh and other key CD4+ T cell results in hyperactive, yet non-protective immune responses that support active viral replication and evolution, and thus persistence in host tissue reservoirs, all of which continue to challenge our efforts to design effective vaccine or cure strategies.
Keywords: HIV-1, SIV, mucosa, gut, CD4, T-cell, cytokine, transcription factors.
[1]
Blattner WA, Biggar RJ, Weiss SH, Melbye M, Goedert JJ. Epidemiology of human T-lymphotropic virus type III and the risk of the acquired immunodeficiency syndrome. Ann Intern Med 1985; 103(5): 665-70.
[4]
Lackner AA, Veazey RS. Current concepts in AIDS pathogenesis: Insights from the SIV/macaque model. Annu Rev Med 2007; 58: 461-76.
[5]
Picker LJ, Hansen SG, Lifson JD. New paradigms for HIV/AIDS vaccine development. Annu Rev Med 2012; 63: 95-111.
[7]
Abraham C, Medzhitov R. Interactions between the host innate immune system and microbes in inflammatory bowel disease. Gastroenterology 2011; 140(6): 1729-37.
[8]
Powell N, Walker MM, Talley NJ. The mucosal immune system: Master regulator of bidirectional gut-brain communications. Nat Rev Gastroenterol Hepatol 2017; 14: 143-59.
[9]
Byrareddy SN, Arthos J, Cicala C, et al. Sustained virologic control in SIV+ macaques after antiretroviral and α4β7 antibody therapy. Science 2016; 354(6309): 197-202.
[10]
Gottlieb MS, Schroff R, Schanker HM, et al. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: Evidence of a new acquired cellular immunodeficiency. N Engl J Med 1981; 305(24): 1425-31.
[11]
Siegal FP, Lopez C, Hammer GS, et al. Severe acquired immunodeficiency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesions. N Engl J Med 1981; 305(24): 1439-44.
[12]
Masur H, Michelis MA, Wormser GP, et al. Opportunistic infection in previously healthy women. Initial manifestations of a community-acquired cellular immunodeficiency. Ann Intern Med 1982; 97(4): 533-9.
[13]
King NW, Hunt RD, Letvin NL. Histopathologic changes in macaques with an Acquired Immunodeficiency Syndrome (AIDS). Am J Pathol 1983; 113(3): 382-8.
[14]
Kotler DP, Gaetz HP, Lange M, Klein EB, Holt PR. Enteropathy associated with the acquired immunodeficiency syndrome. Ann Intern Med 1984; 101(4): 421-8.
[15]
Anton PA, Elliott J, Poles MA, et al. Enhanced levels of functional HIV-1 co-receptors on human mucosal T cells demonstrated using intestinal biopsy tissue. AIDS 2000; 14(12): 1761-5.
[16]
Veazey RS, DeMaria M, Chalifoux LV, et al. Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science 1998; 280(5362): 427-31.
[17]
Veazey RS, Marx PA, Lackner AA. The mucosal immune system: Primary target for HIV infection and AIDS. Trends Immunol 2001; 22(11): 626-33.
[18]
Veazey RS, Marx PA, Lackner AA. Vaginal CD4+ T cells express high levels of CCR5 and are rapidly depleted in Simian Immunodeficiency Virus infection. J Infect Dis 2003; 187(5): 769-76.
[19]
Mehandru S, Poles MA, Tenner-Racz K, et al. Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J Exp Med 2004; 200(6): 761-70.
[20]
Brenchley JM, Schacker TW, Ruff LE, et al. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 2004; 200(6): 749-59.
[22]
Mehandru S, Poles MA, Tenner-Racz K, et al. Mechanisms of gastrointestinal CD4+ T cell depletion during acute and early HIV-1 infection. J Virol 2006; 81: 599-612.
[23]
Veazey RS, Mansfield KG, Tham IC, et al. Dynamics of CCR5 expression by CD4(+) T cells in lymphoid tissues during Simian Immunodeficiency Virus infection. J Virol 2000; 74(23): 11001-7.
[24]
Olsson J, Poles M, Spetz AL, et al. Human Immunodeficiency Virus type 1 infection is associated with significant mucosal inflammation characterized by increased expression of CCR5, CXCR4, and beta-chemokines. J Infect Dis 2000; 182(6): 1625-35.
[25]
Wang X, Xu H, Pahar B, et al. Simian immunodeficiency virus selectively infects proliferating CD4+ T cells in neonatal rhesus macaques. Blood 2010; 116(20): 4168-74.
[26]
Wang X, Rasmussen T, Pahar B, et al. Massive infection and loss of CD4+ T cells occurs in the intestinal tract of neonatal rhesus macaques in acute SIV infection. Blood 2007; 109(3): 1174-81.
[27]
Bunders MJ, van der Loos CM, Klarenbeek PL, et al. Memory CD4(+)CCR5(+) T cells are abundantly present in the gut of newborn infants to facilitate mother-to-child transmission of HIV-1. Blood 2012; 120(22): 4383-90.
[28]
Wang X, Das A, Lackner AA, Veazey RS, Pahar B. Intestinal double-positive CD4+CD8+ T cells of neonatal Rhesus Macaques are proliferating, activated memory cells and primary targets for SIVMAC251 infection. Blood 2008; 112(13): 4981-90.
[29]
Jimenez E, Marin ML, Martin R, et al. Is meconium from healthy newborns actually sterile? Res Microbiol 2008; 159(3): 187-93.
[30]
Aagaard K, Ma J, Antony KM, Ganu R, Petrosino J, Versalovic J. The placenta harbors a unique microbiome. Sci Transl Med 2014; 6(237): 237ra65.
[31]
Chahroudi A, Cartwright E, Lee ST, et al. Target Cell Availability, Rather than breast milk factors, dictates mother-to-infant transmission of SIV in Sooty Mangabeys and Rhesus Macaques. PLoS Pathog 2014; 10(3): e1003958.
[32]
Corneau A, Cosma A, Even S, et al. Comprehensive mass cytometry analysis of cell cycle, activation, and coinhibitory receptors expression in CD4 T Cells from healthy and HIV-Infected individuals. Cytometry B Clin Cytom 2017; 92(1): 21-32.
[33]
Turner DL, Farber DL. Mucosal resident memory CD4 T cells in protection and immunopathology. Front Immunol 2014; 5: 331.
[34]
Collier FM, Tang ML, Martino D, et al. The ontogeny of naive and regulatory CD4(+) T-cell subsets during the first postnatal year: A cohort study. Clin Transl Immunology 2015; 4(3): e34.
[35]
Kunkel EJ, Campbell DJ, Butcher EC. Chemokines in lymphocyte trafficking and intestinal immunity. Microcirculation 2003; 10(3-4): 313-23.
[36]
Gebhardt T, Wakim LM, Eidsmo L, Reading PC, Heath WR, Carbone FR. Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus. Nat Immunol 2009; 10(5): 524-30.
[37]
Teijaro JR, Turner D, Pham Q, Wherry EJ, Lefrancois L, Farber DL. Cutting edge: Tissue-retentive lung memory CD4 T cells mediate optimal protection to respiratory virus infection. J Immunol 2011; 187(11): 5510-4.
[38]
Papadakis KA, Landers C, Prehn J, et al. CC chemokine receptor 9 expression defines a subset of peripheral blood lymphocytes with mucosal T cell phenotype and Th1 or T-regulatory 1 cytokine profile. J Immunol 2003; 171(1): 159-65.
[39]
Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999; 401(6754): 708-12.
[40]
Richards H, Longhi MP, Wright K, Gallimore A, Ager A. CD62L (L-selectin) down-regulation does not affect memory T cell distribution but failure to shed compromises anti-viral immunity. J Immunol 2008; 180(1): 198-206.
[41]
Kim CH, Rott L, Kunkel EJ, et al. Rules of chemokine receptor association with T cell polarization in vivo. J Clin Invest 2001; 108(9): 1331-9.
[42]
Loetscher P, Uguccioni M, Bordoli L, et al. CCR5 is characteristic of Th1 lymphocytes. Nature 1998; 391(6665): 344-5.
[43]
Sallusto F, Mackay CR, Lanzavecchia A. The role of chemokine receptors in primary, effector, and memory immune responses. Annu Rev Immunol 2000; 18: 593-620.
[44]
Breitfeld D, Ohl L, Kremmer E, et al. Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. J Exp Med 2000; 192(11): 1545-52.
[45]
Xu H, Wang X, Malam N, Lackner AA, Veazey RS. Persistent simian immunodeficiency virus infection causes ultimate depletion of follicular Th cells in AIDS. J Immunol 2015; 195(9): 4351-7.
[46]
Xu H, Wang X, Malam N, et al. Persistent Simian Immunodeficiency Virus infection drives differentiation, aberrant accumulation, and latent infection of germinal center follicular T helper cells. J Virol 2015; 90(3): 1578-87.
[47]
Iellem A, Mariani M, Lang R, et al. Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells. J Exp Med 2001; 194(6): 847-53.
[48]
Carbone FR, Mackay LK, Heath WR, Gebhardt T. Distinct resident and recirculating memory T cell subsets in non-lymphoid tissues. Curr Opin Immunol 2013; 25(3): 329-33.
[49]
Veazey RS, Rosenzweig M, Shvetz DE, et al. Characterization of Gut-Associated Lymphoid Tissue (GALT) of normal Rhesus Macaques. Clin Immunol Immunopathol 1997; 82(3): 230-42.
[50]
Sathaliyawala T, Kubota M, Yudanin N, et al. Distribution and compartmentalization of human circulating and tissue-resident memory T cell subsets. Immunity 2013; 38(1): 187-97.
[51]
Wang X, Xu H, Alvarez X, et al. Distinct expression patterns of CD69 in mucosal and systemic lymphoid tissues in primary SIV infection of rhesus macaques. PLoS One 2011; 6(11): e27207.
[52]
Simms PE, Ellis TM. Utility of flow cytometric detection of CD69 expression as a rapid method for determining poly- and oligoclonal lymphocyte activation. Clin Diagn Lab Immunol 1996; 3(3): 301-4.
[53]
Crotty S. Do memory CD4 T cells keep their cell-type programming: Plasticity versus fate commitment? complexities of interpretation due to the heterogeneity of memory CD4 T cells, including T follicular helper cells. Cold Spring Harb Perspect Biol 2017; •••: a029421.
[54]
Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986; 136(7): 2348-57.
[55]
Noack M, Miossec P. Th17 and regulatory T cell balance in autoimmune and inflammatory diseases. Autoimmun Rev 2014; 13(6): 668-77.
[56]
Miossec P, Korn T, Kuchroo VK. Interleukin-17 and type 17 helper T cells. N Engl J Med 2009; 361(9): 888-98.
[57]
Oestreich KJ, Weinmann AS. Master regulators or lineage-specifying? Changing views on CD4+ T cell transcription factors. Nat Rev Immunol 2012; 12(11): 799-804.
[58]
Kiss EA, Diefenbach A. Role of the aryl hydrocarbon receptor in controlling maintenance and functional programs of RORgammat(+) innate lymphoid cells and intraepithelial lymphocytes. Front Immunol 2012; 3: 124.
[59]
Eisenstein EM, Williams CB. The T(reg)/Th17 cell balance: A new paradigm for autoimmunity. Pediatr Res 2009; 65(5 Pt 2): 26R-31R.
[60]
Manel N, Unutmaz D, Littman DR. The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat Immunol 2008; 9(6): 641-9.
[61]
Veldhoen M, Hirota K, Westendorf AM, et al. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 2008; 453(7191): 106-9.
[62]
Wan YY, Flavell RA. How diverse--CD4 effector T cells and their functions. J Mol Cell Biol 2009; 1(1): 20-36.
[63]
Couturier J, Hutchison AT, Medina MA, et al. HIV replication in conjunction with granzyme B production by CCR5+ memory CD4 T cells: Implications for bystander cell and tissue pathologies. Virology 2014; 462-463: 175-88.
[64]
Fevrier M, Dorgham K, Rebollo A. CD4+ T cell depletion in Human Immunodeficiency Virus (HIV) infection: Role of apoptosis. Viruses 2011; 3(5): 586-612.
[65]
Ho IC, Hodge MR, Rooney JW, Glimcher LH. The proto-oncogene c-maf is responsible for tissue-specific expression of interleukin-4. Cell 1996; 85(7): 973-83.
[66]
Zheng W, Flavell RA. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 1997; 89(4): 587-96.
[67]
Yun AJ, Lee PY. The link between T helper balance and lymphoproliferative disease. Med Hypotheses 2005; 65(3): 587-90.
[68]
Olaitan A, Johnson MA, Reid WM, Poulter LW. Changes to the cytokine microenvironment in the genital tract mucosa of HIV+ women. Clin Exp Immunol 1998; 112(1): 100-4.
[69]
Levesque MC, Moody MA, Hwang KK, et al. Polyclonal B cell differentiation and loss of gastrointestinal tract germinal centers in the earliest stages of HIV-1 infection. PLoS Med 2009; 6(7): e1000107.
[70]
Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL. Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis. Science 1994; 265(5176): 1237-40.
[71]
Weiner HL. Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells. Immunol Rev 2001; 182: 207-14.
[72]
Mayne CG, Williams CB. Induced and natural regulatory T cells in the development of inflammatory bowel disease. Inflamm Bowel Dis 2013; 19(8): 1772-88.
[73]
Gol-Ara M, Jadidi-Niaragh F, Sadria R, Azizi G, Mirshafiey A. The role of different subsets of regulatory T cells in immunopathogenesis of rheumatoid arthritis. Arthritis (Egypt) 2012; 2012: 805875.
[74]
Benoist C, Mathis D. Treg cells, life history, and diversity. Cold Spring Harb Perspect Biol 2012; 4(9): a007021.
[75]
Lopez-Abente J, Correa-Rocha R, Pion M. Functional mechanisms of Treg in the context of HIV infection and the Janus Face of immune suppression. Front Immunol 2016; 7: 192.
[76]
Sebastian M, Lopez-Ocasio M, Metidji A, Rieder SA, Shevach EM, Thornton AM. Helios controls a limited subset of regulatory T cell functions. J Immunol 2016; 196(1): 144-55.
[77]
Singh K, Hjort M, Thorvaldson L, Sandler S. Concomitant analysis of Helios and Neuropilin-1 as a marker to detect thymic derived regulatory T cells in naive mice. Sci Rep 2015; 5: 7767.
[78]
Carrier Y, Yuan J, Kuchroo VK, Weiner HL. Th3 cells in peripheral tolerance. I. Induction of Foxp3-positive regulatory T cells by Th3 cells derived from TGF-beta T cell-transgenic mice. J Immunol 2007; 178(1): 179-85.
[79]
Chayavichitsilp P, Buckwalter JV, Krakowski AC, Friedlander SF. Herpes simplex Pediatrics in review / Am Acad Ped 2009; 30(4): 119-29; quiz 30
[80]
Miyara M, Yoshioka Y, Kitoh A, et al. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 2009; 30(6): 899-911.
[81]
Adeegbe DO, Nishikawa H. Natural and induced T regulatory cells in cancer. Front Immunol 2013; 4: 190.
[82]
Bonertz A, Weitz J, Pietsch DH, et al. Antigen-specific Tregs control T cell responses against a limited repertoire of tumor antigens in patients with colorectal carcinoma. J Clin Invest 2009; 119(11): 3311-21.
[83]
Thornton AM, Korty PE, Tran DQ, et al. Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J Immunol 2010; 184(7): 3433-41.
[84]
Vieira PL, Christensen JR, Minaee S, et al. IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells. J Immunol 2004; 172(10): 5986-93.
[85]
Jonuleit H, Schmitt E. The regulatory T cell family: Distinct subsets and their interrelations. J Immunol 2003; 171(12): 6323-7.
[86]
Saurer L, Mueller C. T cell-mediated immunoregulation in the gastrointestinal tract. Allergy 2009; 64(4): 505-19.
[87]
Pozo-Balado MM, Rosado-Sanchez I, Mendez-Lagares G, et al. Maraviroc contributes to the restoration of the homeostasis of
regulatory T-cell subsets in antiretroviral-naive HIV-infected
subjects. Clin Microbiol Infect 2016; 22(5): 461 e1-5.
[88]
Danese S, Rutella S. The Janus face of CD4+CD25+ regulatory T cells in cancer and autoimmunity. Curr Med Chem 2007; 14(6): 649-66.
[89]
Pion M, Jaramillo-Ruiz D, Martinez A, Munoz-Fernandez MA, Correa-Rocha R. HIV infection of human regulatory T cells downregulates Foxp3 expression by increasing DNMT3b levels and DNA methylation in the FOXP3 gene. AIDS 2013; 27(13): 2019-29.
[90]
Card CM, Keynan Y, Lajoie J, et al. HIV controllers are distinguished by chemokine expression profile and HIV-specific T-cell proliferative potential. J Acquir Immune Defic Syndr 2012; 59(5): 427-37.
[91]
Nilsson J, Boasso A, Velilla PA, et al. HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS. Blood 2006; 108(12): 3808-17.
[92]
Presicce P, Orsborn K, King E, Pratt J, Fichtenbaum CJ, Chougnet CA. Frequency of circulating regulatory T cells increases during chronic HIV infection and is largely controlled by highly active antiretroviral therapy. PLoS One 2011; 6(12): e28118.
[93]
Lackner AA, Mohan M, Veazey RS. The gastrointestinal tract and AIDS pathogenesis. Gastroenterology 2009; 136(6): 1965-78.
[94]
Wang X, Xu H, Shen C, et al. Profound loss of intestinal Tregs in acutely SIV-infected neonatal macaques. J Leukoc Biol 2015; 97(2): 391-400.
[95]
Park H, Li Z, Yang XO, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005; 6(11): 1133-41.
[96]
Harrington LE, Hatton RD, Mangan PR, et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005; 6(11): 1123-32.
[97]
Xu H, Wang X, Veazey RS. Th17 cells coordinate with Th22 cells in maintaining homeostasis of intestinal tissues and both are depleted in SIV-Infected Macaques. J AIDS Clin Res 2014; 5(5): 302.
[98]
Plank MW, Kaiko GE, Maltby S, et al. Th22 cells form a distinct Th lineage from Th17 cells in vitro with unique transcriptional properties and Tbet-dependent Th1 plasticity. J Immunol 2017; 198(5): 2182-90.
[99]
Page EE, Greathead L, Metcalf R, et al. Loss of Th22 cells is associated with increased immune activation and IDO-1 activity in HIV-1 infection. J Acquir Immune Defic Syndr 2014; 67(3): 227-35.
[100]
Sallusto F, Zielinski CE, Lanzavecchia A. Human Th17 subsets. Eur J Immunol 2012; 42(9): 2215-20.
[101]
Sun H, Kim D, Li X, et al. Th1/17 polarization of CD4 T cells supports HIV-1 persistence during antiretroviral therapy. J Virol 2015; 89(22): 11284-93.
[102]
Kader M, Bixler S, Roederer M, Veazey R, Mattapallil JJ. CD4 T cell subsets in the mucosa are CD28+Ki-67-HLA-DR-CD69+ but show differential infection based on alpha4beta7 receptor expression during acute SIV infection. J Med Primatol 2009; 38(Suppl. 1): 24-31.
[103]
Alvarez Y, Tuen M, Shen G, et al. Preferential HIV infection of CCR6+ Th17 cells is associated with higher levels of virus receptor expression and lack of CCR5 ligands. J Virol 2013; 87(19): 10843-54.
[104]
Gosselin A, Wiche Salinas TR, Planas D, et al. HIV persists in CCR6+CD4+ T cells from colon and blood during antiretroviral therapy. AIDS 2017; 31(1): 35-48.
[105]
Xu H, Wang X, Liu DX, Moroney-Rasmussen T, Lackner AA, Veazey RS. IL-17-producing innate lymphoid cells are restricted to mucosal tissues and are depleted in SIV-infected macaques. Mucosal Immunol 2012; 5(6): 658-69.
[106]
Sonnenberg GF, Monticelli LA, Alenghat T, et al. Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria. Science 2012; 336(6086): 1321-5.
[107]
Lee JS, Tato CM, Joyce-Shaikh B, et al. Interleukin-23-independent IL-17 production regulates intestinal epithelial permeability. Immunity 2015; 43(4): 727-38.
[108]
Ryan ES, Micci L, Fromentin R, et al. Loss of function of intestinal IL-17 and IL-22 producing cells contributes to inflammation and viral persistence in SIV-Infected Rhesus Macaques. PLoS Pathog 2016; 12(2): e1005412.
[109]
Serriari NE, Eoche M, Lamotte L, et al. Innate Mucosal-Associated Invariant T (MAIT) cells are activated in inflammatory bowel diseases. Clin Exp Immunol 2014; 176(2): 266-74.
[110]
Cecchinato V, Franchini G. Th17 cells in pathogenic simian immunodeficiency virus infection of macaques. Curr Opin HIV AIDS 2010; 5(2): 141-5.
[111]
Brenchley JM, Paiardini M, Knox KS, et al. Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. Blood 2008; 112(7): 2826-35.
[112]
Dandekar S, George MD, Baumler AJ. Th17 cells, HIV and the gut mucosal barrier. Curr Opin HIV AIDS 2010; 5(2): 173-8.
[113]
Kanwar B, Favre D, McCune JM. Th17 and regulatory T cells: Implications for AIDS pathogenesis. Curr Opin HIV AIDS 2010; 5(2): 151-7.
[114]
Raffatellu M, Santos RL, Verhoeven DE, et al. Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. Nat Med 2008; 14(4): 421-8.
[115]
Mitsuki YY, Tuen M, Hioe CE. Differential effects of HIV transmission from monocyte-derived dendritic cells vs. monocytes to IL-17+CD4+ T cells. J Leukoc Biol 2017; 101(1): 339-50.
[116]
Stieh DJ, Matias E, Xu H, et al. Th17 cells are preferentially infected very early after vaginal transmission of SIV in Macaques. Cell Host Microbe 2016; 19(4): 529-40.
[117]
Cleret-Buhot A, Zhang Y, Planas D, et al. Identification of novel HIV-1 dependency factors in primary CCR4(+)CCR6(+)Th17 cells via a genome-wide transcriptional approach. Retrovirology 2015; 12: 102.
[118]
Lee GQ, Lichterfeld M. Diversity of HIV-1 reservoirs in CD4+ T-cell subpopulations. Curr Opin HIV AIDS 2016; 11(4): 383-7.
[119]
El Hed A, Khaitan A, Kozhaya L, et al. Susceptibility of human Th17 cells to human immunodeficiency virus and their perturbation during infection. J Infect Dis 2010; 201(6): 843-54.
[120]
Christensen-Quick A, Lafferty M, Sun L, Marchionni L, DeVico A, Garzino-Demo A. Human Th17 cells lack HIV-inhibitory RNases and are hghly permissive to productive HIV infection. J Virol 2016; 90(17): 7833-47.
[121]
Brenchley JM, Price DA, Schacker TW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006; 12(12): 1365-71.
[122]
Klatt NR, Chomont N, Douek DC, Deeks SG. Immune activation and HIV persistence: Implications for curative approaches to HIV infection. Immunol Rev 2013; 254(1): 326-42.
[123]
Ortiz AM, Klase ZA, DiNapoli SR, et al. IL-21 and probiotic therapy improve Th17 frequencies, microbial translocation, and microbiome in ARV-treated, SIV-infected macaques. Mucosal Immunol 2016; 9(2): 458-67.
[124]
Pallikkuth S, Micci L, Ende ZS, et al. Maintenance of intestinal Th17 cells and reduced microbial translocation in SIV-infected rhesus macaques treated with interleukin (IL)-21. PLoS Pathog 2013; 9(7): e1003471.
[125]
Perreau M, Savoye AL, De Crignis E, et al. Follicular helper T cells serve as the major CD4 T cell compartment for HIV-1 infection, replication, and production. J Exp Med 2013; 210(1): 143-56.
[126]
Cubas RA, Mudd JC, Savoye AL, et al. Inadequate T follicular cell help impairs B cell immunity during HIV infection. Nat Med 2013; 19(4): 494-9.
[127]
Ma CS, Phan TG. Here, there and everywhere: T follicular helper cells on the move. Immunology 2017; 152(3): 382-7.
[128]
Moukambi F, Rodrigues V, Fortier Y, et al. CD4 T follicular helper cells and HIV infection: Friends or enemies? Front Immunol 2017; 8: 135.
[129]
Xu H, Wang X, Lackner AA, Veazey RS. PD-1(HIGH) follicular CD4 T helper cell subsets residing in lymph node germinal centers correlate with B cell maturation and IgG production in Rhesus Macaques. Front Immunol 2014; 5: 85.
[130]
Xu H, Wang X, Malam N, et al. Persistent Simian Immunodeficiency Virus infection drives differentiation, aberrant accumulation, and latent infection of germinal center Follicular T helper cells. J Virol 2016; 90(3): 1578-87.
[131]
Morita R, Schmitt N, Bentebibel SE, et al. Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity 2011; 34(1): 108-21.
[132]
Miller SM, Miles B, Guo K, et al. Follicular regulatory T cells are highly permissive to R5-tropic HIV-1. J Virol 2017; 91(17): e00430-17.
[133]
Zaunders J, Xu Y, Kent SJ, Koelsch KK, Kelleher AD. Divergent Expression of CXCR5 and CCR5 on CD4+ T Cells and the Paradoxical Accumulation of T Follicular Helper Cells during HIV Infection. Front Immunol 2017; 8: 495.
[134]
Krautler NJ, Suan D, Butt D, et al. Differentiation of germinal center B cells into plasma cells is initiated by high-affinity antigen and completed by Tfh cells. J Exp Med 2017; 214(5): 1259-67.
[135]
Ling B, Mohan M, Lackner AA, et al. The large intestine as a major reservoir for simian immunodeficiency virus in macaques with long-term, nonprogressing infection. J Infect Dis 2010; 202(12): 1846-54.
[136]
Apostolaki M, Manoloukos M, Roulis M, et al. Role of beta7 integrin and the chemokine/chemokine receptor pair CCL25/CCR9 in modeled TNF-dependent Crohn’s disease. Gastroenterology 2008; 134(7): 2025-35.
[137]
Wagner N, Lohler J, Kunkel EJ, et al. Critical role for b7 integrins in formation of the gut-associated lymphoid tissue. Nature 1996; 382: 366-70.
[138]
Cepek KL, Shaw SK, Parker CM, et al. Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the alpha E beta 7 integrin. Nature 1994; 372(6502): 190-3.
[139]
Mavigner M, Cazabat M, Dubois M, et al. Altered CD4+ T cell homing to the gut impairs mucosal immune reconstitution in treated HIV-infected individuals. J Clin Invest 2012; 122(1): 62-9.
[140]
Parra M, Herrera D, Calvo-Calle JM, et al. Circulating human rotavirus specific CD4 T cells identified with a class II tetramer express the intestinal homing receptors alpha4beta7 and CCR9. Virology 2014; 452-453: 191-201.
[142]
Arthos J, Cicala C, Martinelli E, et al. HIV-1 envelope protein binds to and signals through integrin alpha4beta7, the gut mucosal homing receptor for peripheral T cells. Nat Immunol 2008; 9(3): 301-9.
[143]
Guzzo C, Ichikawa D, Park C, et al. Virion incorporation of integrin alpha4beta7 facilitates HIV-1 infection and intestinal homing. Sci Immunol 2017; 2(11): eaam7341.
[144]
Byrareddy SN, Kallam B, Arthos J, et al. Targeting alpha4beta7 integrin reduces mucosal transmission of simian immunodeficiency virus and protects gut-associated lymphoid tissue from infection. Nat Med 2014; 20(12): 1397-400.
[145]
Ansari AA, Reimann KA, Mayne AE, et al. Blocking of alpha4beta7 gut-homing integrin during acute infection leads to decreased plasma and gastrointestinal tissue viral loads in simian immunodeficiency virus-infected rhesus macaques. J Immunol 2011; 186(2): 1044-59.
[146]
Wang X, Xu H, Gill AF, et al. Monitoring alpha4beta7 integrin expression on circulating CD4+ T cells as a surrogate marker for tracking intestinal CD4+ T-cell loss in SIV infection. Mucosal Immunol 2009; 2(6): 518-26.
[147]
Kader M, Wang X, Piatak M, et al. Alpha4(+)beta7(hi)CD4(+) memory T cells harbor most Th-17 cells and are preferentially infected during acute SIV infection. Mucosal Immunol 2009; 2(5): 439-49.
[148]
Pandrea IV, Gautam R, Ribeiro RM, Brenchley JM, Butler IF, Pattison M, et al. Acute loss of intestinal CD4+ T cells is not predictive of simian immunodeficiency virus virulence. J Immunol 2007; 179(5): 3035-46.
[149]
Ling B, Veazey RS, Hart M, et al. Early restoration of mucosal CD4 memory CCR5 T cells in the gut of SIV-infected rhesus predicts long term non-progression. AIDS 2007; 21(18): 2377-85.
[150]
Girard A, Vergnon-Miszczycha D, Depince-Berger AE, et al. Brief Report: A high rate of beta7+ gut-homing lymphocytes in HIV-infected immunological nonresponders is associated with poor CD4 T-Cell Recovery During Suppressive HAART. J Acquir Immune Defic Syndr 2016; 72(3): 259-65.
[151]
Allers K, Puyskens A, Epple HJ, et al. The effect of timing of antiretroviral therapy on CD4+ T-cell reconstitution in the intestine of HIV-infected patients. Mucosal Immunol 2016; 9(1): 265-74.
[152]
George MD, Reay E, Sankaran S, Dandekar S. Early antiretroviral therapy for simian immunodeficiency virus infection leads to mucosal CD4+ T-cell restoration and enhanced gene expression regulating mucosal repair and regeneration. J Virol 2005; 79(5): 2709-19.
[153]
Guadalupe M, Sankaran S, George MD, Reay E, Verhoeven D, Shacklett BL, et al. Viral suppression and immune restoration in the gastrointestinal mucosa of human immunodeficiency virus type 1-infected patients initiating therapy during primary or chronic infection. J Virol 2006; 80(16): 8236-47.
[154]
Hartigan-O’connor DJ, Hirao LA, McCune JM, Dandekar S. Th17 cells and regulatory T cells in elite control over HIV and SIV. Curr Opin HIV AIDS 2011; 6(3): 221-7.
[155]
Rueda CM, Velilla PA, Chougnet CA, Rugeles MT. Incomplete normalization of regulatory t-cell frequency in the gut mucosa of Colombian HIV-infected patients receiving long-term antiretroviral treatment. PLoS One 2013; 8(8): e71062.
[156]
d’Ettorre G, Rossi G, Scagnolari C, et al. Probiotic supplementation promotes a reduction in T-cell activation, an increase in Th17 frequencies, and a recovery of intestinal epithelium integrity and mitochondrial morphology in ART-treated HIV-1-positive patients. Immun Inflamm Dis 2017; 5(3): 244-60.
[157]
Costiniuk CT, Angel JB. Human immunodeficiency virus and the gastrointestinal immune system: does highly active antiretroviral therapy restore gut immunity? Mucosal Immunol 2012; 5(6): 596-604.
[158]
Guadalupe M, Reay E, Sankaran S, et al. Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J Virol 2003; 77(21): 11708-17.
[159]
Verhoeven D, Sankaran S, Silvey M, Dandekar S. Antiviral therapy during primary simian immunodeficiency virus infection fails to prevent acute loss of CD4+ T cells in gut mucosa but enhances their rapid restoration through central memory T cells. J Virol 2008; 82(8): 4016-27.
[160]
Sheth PM, Chege D, Shin LY, et al. Immune reconstitution in the sigmoid colon after long-term HIV therapy. Mucosal Immunol 2008; 1(5): 382-8.
[161]
Yukl SA, Shergill AK, Girling V, et al. Site-specific differences in T cell frequencies and phenotypes in the blood and gut of HIV-uninfected and ART-treated HIV+ adults. PLoS One 2015; 10(3): e0121290.
[162]
Estes J, Baker JV, Brenchley JM, et al. Collagen deposition limits immune reconstitution in the gut. J Infect Dis 2008; 198(4): 456-64.
[163]
Mestecky J, McGhee JR, Bienenstock J, et al. Historical aspects of mucosal immunology.In: Mestecky J, Strober W, Russell MW, Kelsall BL, Cheroutre H, Lambrecht BN, editors. Mucosal immunology. 1. Amsterdam: Elsevier; 2015. p. xxxi-lvii.
[164]
Waksman BH, Ozer H. Specialized amplification elements in the immune system. The role of nodular lymphoid organs in the mucous membranes. Prog Allergy 1976; 21: 1-113.
[165]
Yasuda M, Jenne CN, Kennedy LJ, Reynolds JD. The sheep and cattle Peyer’s patch as a site of B-cell development. Vet Res 2006; 37(3): 401-15.
[166]
Yanai H, Atsumi N, Tanaka T, et al. Intestinal stem cells contribute to the maturation of the neonatal small intestine and colon independently of digestive activity. Sci Rep 2017; 7(1): 9891.
[167]
Saito H, Kanamori Y, Takemori T, et al. Generation of intestinal T cells from progenitors residing in gut cryptopatches. Science 1998; 280(5361): 275-8.
[168]
Guy-Grand D, Azogui O, Celli S, Darche S, Nussenzweig MC, Kourilsky P, et al. Extrathymic T cell lymphopoiesis: Ontogeny and contribution to gut intraepithelial lymphocytes in athymic and euthymic mice. J Exp Med 2003; 197(3): 333-41.
[169]
Lugering A, Ross M, Sieker M, et al. CCR6 identifies lymphoid tissue inducer cells within cryptopatches. Clin Exp Immunol 2010; 160(3): 440-9.
[170]
Lugli E, Gattinoni L, Roberto A, et al. Identification, isolation and in vitro expansion of human and nonhuman primate T stem cell memory cells. Nat Protoc 2013; 8(1): 33-42.
[171]
Lu X, Song B, Weng W, Xia H, Su B, Wu H, et al. CD4+ T Memory Stem Cells Correlate with Disease Progression in Chronically HIV-1-Infected Patients. Viral Immunol 2017; 30(9): 642-8.
[172]
Chahroudi A, Silvestri G, Lichterfeld M. T memory stem cells and HIV: A long-term relationship. Curr HIV/AIDS Rep 2015; 12(1): 33-40.
[173]
Gray GE, Moodie Z, Metch B, et al. Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study. Lancet Infect Dis 2014; 14(5): 388-96.
Article Metrics
87
4